IMM 20.3% 35.5¢ immutep limited

dr goh - october interim data, page-12

  1. 1,770 Posts.
    And in support of the sentiments posted in this thread, let us not forget boiler's post.

    "The FDA approval for Phase 3 has been granted as per the entry on the ClinicalTrials.gov website, date of entry January 29, 2012. Marty will make an announcement to the market to confirm this significant milestone for Prima. The market needs to wake up and realise that the approval means that phase 2b is a success otherwise we wouldn't be running with an FDA approved Phase 3 trial, Hello any one home".

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.060(20.3%)
Mkt cap ! $515.6M
Open High Low Value Volume
36.0¢ 37.5¢ 33.5¢ $6.427M 18.03M

Buyers (Bids)

No. Vol. Price($)
1 50000 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 133736 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.